The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study

Marta Di Forti*, Diego Quattrone, Tom P. Freeman, Giada Tripoli, Charlotte Gayer-Anderson, Harriet Quigley, Victoria Rodriguez, Hannah E. Jongsma, Laura Ferraro, Caterina La Cascia, Daniele La Barbera, Ilaria Tarricone, Domenico Berardi, Andrei Szoke, Celso Arango, Andrea Tortelli, Eva Velthorst, Miguel Bernardo, Cristina Marta Del-Ben, Paulo Rossi MenezesJean-Paul Selten, Peter B. Jones, James B. Kirkbride, Bart P. F. Rutten, Lieuwe de Haan, Pak C. Sham, Jim van Os, Cathryn M. Lewis, Michael Lynskey, Craig Morgan, Robin M. Murray, EU-GEI WP2 Group

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)427-436
Number of pages10
JournalLancet Psychiatry
Volume6
Issue number5
DOIs
Publication statusPublished - May 2019

Keywords

  • HIGH-POTENCY CANNABIS
  • PUBLIC-HEALTH
  • RISK
  • MARIJUANA
  • TRENDS
  • SCHIZOPHRENIA
  • ASSOCIATION
  • ENGLAND
  • LONDON

Cite this